A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
Clinical trial NCT03246347 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03246347
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2022-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.